Literature DB >> 20055894

Lithocholic acid downregulates vitamin D effects in human osteoblasts.

S Ruiz-Gaspà1, N Guañabens, A Enjuanes, P Peris, A Martinez-Ferrer, M J Martinez de Osaba, B Gonzalez, L Alvarez, A Monegal, A Combalia, A Parés.   

Abstract

BACKGROUND: Osteoporosis is a common complication in chronic cholestasis. It has been proposed that retained substances such as bile acids may produce a damaging effect on bone cells. This study analyses the effects of lithocholic acid (LCA) on cell survival and vitamin D metabolism in human osteoblasts (hOB).
MATERIALS AND METHODS: Human osteoblasts cultures were performed with or without foetal bovine serum (FBS) or human albumin (HA) at different LCA concentrations and times with or without vitamin D.
RESULTS: Lithocholic acid at concentrations higher than 10(-5 )M decreased cell survival. This effect was partially prevented by the presence of FBS or HA. Vitamin D stimulated CYP24A, BGLAP and TNFSF11 expression in hOB and these effects were modified by nontoxic LCA concentrations. LCA significantly decreased vitamin D stimulation of CYP24A, BGLAP and TNFSF11 gene expression at 72%, 79% and 56% (respectively). LCA alone has an agonistic effect, as has vitamin D, thus partially increasing CYP24A and BGLAP expression, but with no changes on TNFRSF11B expression. Equivalent effects of the LCA were observed by performing gene reporter assays using MG-63 cells transfected with constructs containing CYP24A1 promoter regions.
CONCLUSIONS: Lithocholic acid decreases the stimulatory effect of vitamin D on CYP24A, BGLAP and TNFSF11 expression in hOB. This effect is produced through vitamin D response elements (VDREs), located in the promoter regions of these genes, suggesting that LCA acts as a mild analogous of vitamin D, interacting with the vitamin D receptor. These results may explain the potential deleterious effects of retained bile acids on hOB.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20055894     DOI: 10.1111/j.1365-2362.2009.02230.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  16 in total

Review 1.  Targeting DNA polymerase ß for therapeutic intervention.

Authors:  Eva M Goellner; David Svilar; Karen H Almeida; Robert W Sobol
Journal:  Curr Mol Pharmacol       Date:  2012-01       Impact factor: 3.339

2.  Association between primary biliary cholangitis and osteoporosis: meta-analysis.

Authors:  Junyu Fan; Qian Wang; Lingyun Sun
Journal:  Clin Rheumatol       Date:  2017-09-26       Impact factor: 2.980

3.  Modeling hepatic osteodystrophy in Abcb4 deficient mice.

Authors:  Katrin Hochrath; Sabrina Ehnert; Cheryl L Ackert-Bicknell; Yvonne Lau; Andrea Schmid; Marcin Krawczyk; Jan G Hengstler; Jordanne Dunn; Kanishka Hiththetiya; Birgit Rathkolb; Kateryna Micklich; Wolfgang Hans; Helmut Fuchs; Valérie Gailus-Durner; Eckhard Wolf; Martin Hrabě de Angelis; Steven Dooley; Beverly Paigen; Britt Wildemann; Frank Lammert; Andreas K Nüssler
Journal:  Bone       Date:  2013-03-29       Impact factor: 4.398

Review 4.  Nuclear receptors as drug targets in cholestatic liver diseases.

Authors:  Emina Halilbasic; Anna Baghdasaryan; Michael Trauner
Journal:  Clin Liver Dis       Date:  2013-05       Impact factor: 6.126

Review 5.  Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis: a Review Featuring a Women's Health Perspective.

Authors:  Renée M Marchioni Beery; Haleh Vaziri; Faripour Forouhar
Journal:  J Clin Transl Hepatol       Date:  2014-12-15

Review 6.  Diagnosis and Management of Cirrhosis-Related Osteoporosis.

Authors:  Lívia Alves Amaral Santos; Fernando Gomes Romeiro
Journal:  Biomed Res Int       Date:  2016-10-20       Impact factor: 3.411

7.  Metabolic alterations in the bone tissues of aged osteoporotic mice.

Authors:  Miso Nam; Jeong-Eun Huh; Min-Sun Kim; Do Hyun Ryu; Jihyeong Park; Han-Sung Kim; Soo Young Lee; Geum-Sook Hwang
Journal:  Sci Rep       Date:  2018-05-25       Impact factor: 4.379

Review 8.  Osteoporosis in primary biliary cholangitis.

Authors:  Christopher J Danford; Hirsh D Trivedi; Konstantinos Papamichael; Elliot B Tapper; Alan Bonder
Journal:  World J Gastroenterol       Date:  2018-08-21       Impact factor: 5.742

9.  Lithocholic Acid Is a Vitamin D Receptor Ligand That Acts Preferentially in the Ileum.

Authors:  Michiyasu Ishizawa; Daisuke Akagi; Makoto Makishima
Journal:  Int J Mol Sci       Date:  2018-07-06       Impact factor: 5.923

10.  Vitamin D modulates biliary fibrosis in ABCB4-deficient mice.

Authors:  Katrin Hochrath; Caroline S Stokes; Jürgen Geisel; Marion J Pollheimer; Peter Fickert; Steven Dooley; Frank Lammert
Journal:  Hepatol Int       Date:  2014-06-21       Impact factor: 6.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.